1.Centers for Disease Control. Recommendations for prevention of HIV transmission in health-care settings. MMWR 1987; 36: 1S–18S.
2.Department of Health. Health Circular HC(91)33. Decontamination of equipment, linen, or other surfaces contaminated with hepatitis-B and/or human immunodeficiency virus. London: Department of Health. 1991.
3.WHO. Guidelines on sterilization and disinfection methods effective against human immunodeficiency virus (HIV). Geneva: WHO AIDS. 1989: Series 2.
4.Dychdala, GR. Chlorine and chlorine compounds. In: Block, SS. ed. Disinfection, sterilization and preservation. Philadelphia: Lea and Febiger. 1991; 131–51.
5.Ortenzio, LF, Stuart, LS. The behaviour of chlorine-bearing organic compounds in the A.O.A.C. available chlorine germicidal equivalent concentration test. J Assoc Off Agricult Chemists 1959; 42: 630–3.
6.Trueman, JR. The halogens. In: Hugo, WB. ed. Inhibition and destruction of the microbial cell. London: Academic Press. 1971: 137–83.
7.van Bueren, J, Simpson, RA, Jacobs, P, Cookson, BD. Survival of HIV in suspension and dried onto surfaces. J Clin Microbiol 1994; 32: 571–4.
8.British Standards Institution BS 6424. British Standard specification for QAC based aromatic disinfectant fluids. London: BSI. 1984.
9.Bayliss, GJ, Jesson, JW, Mortimer, PP, McLean, KA, Evans, BA. Cultivation of human immunodeficiency virus from whole blood. J Med Virol 1990; 31: 161–4.
10.Kärber, G. Beitrag zur kollektiven behandlung pharmakologischer reihenversuche. Arch Exp Path Pharm 1931; 162: 480–3.
11.Mosmann, T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983; 65: 55–63.
12.Hoffman, PN, Death, JE, Coates, D. The stability of sodium hypochlorite solutions. S. A. B. Technical Series 1981; 16: 77–83.
13.American Public Health Association. Standard methods for examination of water and waste water. New York: American Public Health Association, 1976: 329–32.
14.Coates, D. Relative stability of sodium hypochlorite liquids and sodium dichloro-isocyanurate effervescent disinfectant tablets. J Hosp Infect 1987; 10: 96–7.
15.Fabian, TM, Walker, SE. Stability of sodium hypochlorite solutions. Am J Hosp Pharm 1982; 39: 1016–7.
16.Bloomfield, SF, Smith-Burchnell, CA, Dalgleish, AG. Evaluation of hypochlorite-releasing disinfectants against the human immunodeficiency virus (HIV). J Hosp Infect 1990; 15: 273–8.
17.Benarde, MA, Israel, BM, Olivieri, VP, Ganstrom, ML. Efficiency of chlorine dioxide as a bactericide. Appl Microbiol 1965; 13: 776–80.
18.Benarde, MA, Snow, WB, Olivieri, VP. Chlorine dioxide disinfection temperature effects. J Appl Bacteriol 1967; 30: 159–67.
19.Benarde, MA, Snow, WB, Olivieri, VP, Davidson, B. Kinetics and mechanism of bacterial disinfection by chlorine dioxide. Appl Microbiol 1967; 15: 257–65.
20.Cousins, CM, Allan, CD. Sporicidal properties of some halogens. J Appl Baeteriol 1967; 30: 168–74.
21.Cousins, CM, Hoy, WA, Clegg, LFL. The evaluation of surfaee active disinfectants for use in milk production. J Appl Baeteriol 1960; 23: 359–71.
22.Weber, GR, Levine, M. Factors affecting germicidal efficiency of chlorine and chloramine. Am J Public Health 1944; 34: 719–28.
23.Ho, DD, Moudgil, T, Alain, M. Quantitation of human immunodeficiency virus type-1 in the blood of infected persons. N Engl J Med 1989; 321: 1621–5.
24.Masquelier, B, Faivre, R, Paty, MC, Fleury, HJA. HIV-1 quantitation in infected patients: a comparison of cell viraemia, plasma viraemia and R-HEV. Res Virol 1992; 143: 17–22.
25.Bloomfield, SF, Miller, EA. A comparison of hypochlorite and phenolic disinfectants for disinfection of clean and soiled surfaces and blood spillages. J Hosp Infect 1989; 13: 231–9.
26.Aranda-Anzaldo, A, Viza, D, Busnel, RG. Chemical inactivation of human immunodeficiency virus in vitro. J Virol Meth 1992; 37: 71–82.
27.Martin, LS, McDougal, JS, Loskoski, SL. Disinfection and inactivation of the human T lymphotropic virus type III/lymphadenopathy-assoeiated virus. J Infect Dis 1985; 152: 400–3.
28.Resnick, L, Veren, K, Salahuddin, SZ, Tondreau, S, Markham, PD. Stability and inactivation of HTLV-III/LAV under clinical and laboratory environments. JAMA 1986; 255: 1887–91.
29.Shapshak, P, McCoy, CB, Rivers, JE et al. , Inactivation of human immunodeficiency virus-1 at short time intervals using undiluted bleach. AIDS 1993; 6: 218–9.
30.Spire, B, Barré-Sinoussi, F, Montagnier, L, Chermann, JC. Inactivation of lymphadenopathy associated virus bv chemical disinfectants. Lancet 1984; ii: 899–901.
31.Coates, D, Wilson, M. Use of dichloroisocyanurate granules for spills of body fluids. J Hosp Infect 1989; 13: 241–51.
32.Coates, D, Wilson, M, Powders, composed of chlorine-releasing agent acrylic resin mixtures or based on peroxygen compounds, for spills of body fluids. J Hosp Infect 1992; 21: 241–52.